Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Methotrexate subcutaneous auto-injection - Medac Pharma

Next Previous
X
Search
Drug Profile

Methotrexate subcutaneous auto-injection - Medac Pharma

Alternative Names: Metex; Methotrexate ready-to-use autopen; Metoject; Metoject® prefilled pen; Metojet® PEN; MJK-101; MPI-2505; Rasuvo; Subcutaneous injectable MTX - Medac Pharma

Latest Information Update: 14 Jun 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medac; Medac Pharma
  • Developer China Medical System; Medac; Medac Pharma
  • Class Abortifacients; Anti-inflammatories; Antiasthmatics; Antifibrotics; Antineoplastics; Antipsoriatics; Antirheumatics; Benzamides; Disease-modifying antirheumatics; Eye disorder therapies; Glutamates; Heart failure therapies; Pterins; Small molecules
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Juvenile rheumatoid arthritis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis

Most Recent Events

  • 27 Mar 2023 Launched for Juvenile rheumatoid arthritis in Denmark, Portugal, Norway, Germany, Finland, Greece, Finland, France, Portugal, Poland, Spain, Czech Republic, United Kingdom, Austria, Hungary, Netherlands, Sweden (SC) before March 2023
  • 27 Mar 2023 Launched for Psoriasis in Denmark, Poland, Portugal, Norway, Germany, France, Greece, Finland, Ireland, Czech Republic, Spain, United Kingdom, Austria, Hungary, Sweden, Netherlands (SC) before March 2023
  • 27 Mar 2023 Launched for Psoriatic arthritis in Denmark, Poland, Portugal, Portugal, Norway, Germany, France, Ireland, Spain, Czech Republic, Austria, Hungary, Netherlands, Sweden (SC) before March 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top